Preparing recombinant single chain antibodies

Chemical Engineering Science

Volumn 63, Issue 6, 2008, Pages 1401-1414

  Leong, Susanna S J ^a   Chen, Wei Ning ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Biomolecular engineering; Biomolecule; Processing; Protein; Recombinant antibodies; Single chain variable fragment

Indexed keywords

ANTIGENS; BIOMOLECULES; CONSTRAINT THEORY; IMMUNOLOGY;

BIOMOLECULAR ENGINEERING; RECOMBINANT ANTIBODIES; SINGLE CHAIN VARIABLE FRAGMENT;

ANTIBODIES;

ANTIBODIES; ANTIGENS; BIOMOLECULES; CONSTRAINT THEORY; IMMUNOLOGY;

EID: 38949210239     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2007.11.022     Document Type: Review

References (139)

1. Adamson C.S., Yao Y., Vasiljevic S., Sy M.S., Ren J., and Jones I.M. Novel single chain antibodies to the prion protein identified by phage display. Virology 358 (2007) 166-177
2. Arbabi-Ghahroudi M., Tanha J., and MacKenzie R. Prokaryotic expression of antibodies. Cancer and Metastasis Reviews 24 (2005) 501-519
3. Arndt K.M., Muller K.M., and Pluckthun A. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. Biochemistry 37 (1998) 12918-12926
4. Aubrey N., Devaux C., di Luccio E., Goyffon M., Rochat H., and Billiald P. Recombinant scFv/streptavidin-binding peptide fusion protein for the quantitative determination of the scorpion venom neurotoxin Aahl. Biological Chemistry 382 (2001) 1621-1628
5. Bach H., Mazor Y., Shaky S., Shoham-Lev A., Berdichevsky Y., Gutnick D.L., and Benhar I. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies. Journal of Molecular Biology 312 (2001) 79-93
6. Banki M.R., and Wood D.W. Inteins and affinity resin substitutes for protein purification and scale up. Microbial Cell Factories 4:32 (2005) 1-6
7. Bannister D., Wilson A., Prowse L., Walsh M., Holgate R., Jermutus L., and Wilkinson T. Parallel high-throughput purification of recombinant antibodies for in vivo cell assays. Biotechnology and Bioengineering 94 (2006) 931-937
8. Batra S.K., Jain M., Wittel U.A., Chauhan S.C., and Colcher D. Pharmacokinetics and biodistribution of genetically engineered antibodies. Current Opinion in Biotechnology 13 (2002) 603-608
9. Begent R.H.J., Verhaar M.J., Chester K.A., Casey J.L., Green A.J., Napier M.P., Hopestone L.D., Cushen N., Keep P.A., Johnson C.J., Hawkins R.E., Hilson A.J.W., and Robson L. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nature Medicine 2 (1996) 979-984
10. Bessette P.H., Aslund F., Beckwith J., and Georgiou G. Efficient folding of proteins with multiple disulphide bonds in the Escherichia coli cytoplasm. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 13703-13708
11. Better M., Chang C.P., Robinson R.R., and Horwitz A.H. Escherichia coli secretion of an active chimeric antibody fragment. Science 242 (1988) 1041-1043
12. Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.M., Lee T., Pope S.H., Riordan G.S., and Whitlow M. Single-chain antigen-binding proteins. Science 242 (1988) 423-426
13. Blank K., Lindner P., Diefenback B., and Pluckthun A. Self-immobilising recombinant antibody fragments for immunoaffinity chromatography: generic, parallel, and scalable protein purification. Protein Expression and Purification 24 (2002) 313-322
14. Braren I., Greunke K., Umland O., Deckers S., Bredehorst R., and Spillner E. Comparative expression of different antibody formats in mammalian cells and Pichia pastoris. Biotechnology and Applied Biochemistry 47 (2007) 205-214
15. Bregegere F., Schwartz J., and Bedoulle H. Bifunctional hybrids between the variable domains of an immunoglobulin and the maltose-binding protein of Escherichia coli-production, purification and antigen-binding. Protein Engineering 7 (1994) 271-280
16. Bremer E., ten Cate B., Samplonius D.F., de Leij L.F.M., and Helfrich W. CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukaemia. Immunobiology 107 (2006) 2863-2870
17. Cao P., Tang X.M., Guan Z.B., Diao Z.Y., and Zhang S.Q. Production and characterization of a bacterial single-chain antibody fragment specific to B-cell-activating factor of the TNF family. Protein Expression and Purification 43 (2005) 157-164
18. Carrier M., Ménasché P., Levy J.H., Newman M.F., Taylor K.M., Haverich A., Chen J.C., Shernan S.K., Van de Werf F., Van der Laan M., Todaro T.G., Adams P.X., and Verrier E.D. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery 131 (2006) 352-356
19. Chames P., Fieschi J., and Batty D. Production of a soluble and active MBP-scFv fusion: favourable effect of the leaky tolR strain. FEBS Letters 405 (1997) 224-228
20. Chapman A.P. PEGylated antibodies and antibody fragments for improved therapy: a review. Advanced Drug Delivery Reviews 54 (2002) 531-545
21. Chen C., Snedecor B., Nishibara J.C., Joly J.C., McFarland N., Andersen D.C., Battersby J.E., and Champion K.M. High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain. Biotechnology and Bioengineering 85 (2004) 463-474
22. Chen J., Xie W.H., Zhang Z.P., Zhang X.E., Li W., Wang S.H., Zhou Y.F., Liang M.F., Wang K.M., and Yang Z.Q. Construction of three single-chain antibody fragment variable fusion structures for sensitive detection of nucleocapsid protein of Hantaan virus. Analytical Letters 39 (2006) 2153-2167
23. Cohen P.A., Mani J.C., and Lane D.P. Characterization of a new intrabody directed against the N-terminal region of human p53. Oncogene 17 (1998) 2445-2456
24. Cregg J.M., Vedvick T.S., and Raschke W.C. Recent advances in the expression of foreign genes in Pichia pastoris. BioTechnology 11 (1993) 905-910
25. Cumbers S.J., Williams G.T., Davies S.L., Grenfell R.L., Takeda S., Batista F.D., Sale J.E., and Neuberger M.S. Generation and iterative affinity maturation of antibodies in vitro using hypermutating B-cell lines. Nature Biotechnology 20 (2002) 1129-1134
26. Cunha A.E., Clemente J.J., Gomes R., Pinto F., Thomaz M., Miranda S., Pinto R., Moosmayer D., Donner P., and Carrondo M.J. Methanol induction optimization for scFv antibody fragment production in Pichia pastoris. Biotechnology and Bioengineering 86 (2004) 458-467
27. Damasceno L.M., Pla I., Chang H.J., Cohen L., Ritter G., Old L.J., and Batt C.A. An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris. Protein Expression and Purification 37 (2004) 18-26
28. Daugherty P.S., Chen G., Olsen M.J., Iverson B.L., and Georgiou G. Antibody affinity maturation using bacterial surface display. Protein Engineering 11 (1998) 825-832
29. De Jonge J., Heirman C., de Veerman M., Van Meirvenne S., Moser M., Leo O., and Thielemans K. In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD 3 × anti-idiotype), induces long-term survival in the murine BCL1 lymphoma model. Journal of Immunology 161 (1998) 1454-1461
30. Dennis M.S., Zhang M., Meng Y.G., Kadkhodayan M., Kirchhofer D., Combs D., and Damico L.A. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. Journal of Biological Chemistry 277 (2002) 35035-35043
31. Dorai H., McCartney J.E., Hudziak R.M., Tai M.S., Laminet A.A., Houston L.L., Huston J.S., and Oppermann H. Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains. BioTechnology 12 (1994) 890-897
32. Du X.B., Sun Y., Lin F., Zheng K.Y., Wang K.W., Lin T.T., Liu J.Q., Shen J.C., and Luo G.M. Chemical chaperones increasing expression level of soluble single-chain Fv antibody (scFv2F3). Chemical Research in Chinese Universities 23 (2007) 69-75
33. Duenas M., Vazquez J., Ayala M., Soderlind E., Ohlin M., Perez L., Borrebaeck C.A., and Gavilondo J.V. Intra- and extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial strains and pathway engineering using GroES/L chaperonins. BioTechniques 16 (1994) 476-482
34. Eldin P., Pauza M.E., Hieda Y., Lin G., Murtaugh M.P., Pentel P.R., and Pennell P.A. High-level secretion of two antibody single-chain Fv fragments by Pichia pastoris. Journal of Immunological Methods 201 (1997) 67-75
35. Eshhar Z., Waks T., Gross G., and Schindler D.G. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 720-724
36. Feldhaus M.J., and Siegel R.W. Yeast display of antibody fragments: a discovery and characterization platform. Journal of Immunological Methods 290 (2004) 69-80
37. Fiedler U., and Conrad U. High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds. BioTechnology 13 (1995) 1090-1093
38. Fipula D. Antibody engineering and modification technologies. Biomolecular Engineering 24 (2007) 201-215
39. Fischer R., Drossard J., Emans N., Commandeur U., and Hellwig S. Towards molecular farming in the future: Pichia pastoris-based production of single-chain antibody fragments. Biotechnology and Applied Biochemistry 30 (1999) 117-120
40. Freyre F.M., Vázquez J.E., Ayala M., Canaán-Haden L., Bell H., Rodríguez I., González A., Cintado A., and Gavilondo J.V. Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastoris. Journal of Biotechnology 76 (2000) 157-163
41. Friedman P.N., Chace D.F., Trail P.A., and Siegall C.B. Antitumour activity of the single chain immunotoxin BR96 sFv-PE40 against established breast and lung tumour xenografts. Journal of Immunology 150 (1993) 3054-3061
42. Galeffi P., Lombardi A., Pietraforte I., Novelli F., Di Donato M., Sperandei M., Tornambe A., Fraioli R., Benevolo P.G., Benevolo M., Mottolese M., Ylera F., Cantale C., and Giacomini P. Functional expression of a single-chain antibody to ErbB-2 in plants and cell-free systems. Journal of Translational Medicine 4:39 (2006) 1-13
43. Gasser B., and Mattanovich D. Antibody production with yeasts and filamentous fungi: on the road to large scale?. Biotechnology Letters 29 (2007) 201-212
44. Glockshuber R., Schmidt T., and Pluckthun A. The disulphide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in E. coli. Biochemistry 31 (1992) 1270-1279
45. Goel A., Colcher D., Baranowska-Kortylewicz J., Augustine S., Booth B.J.M., Pavlinkova G., and Batra S.K. Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application. Cancer Research 60 (2000) 6964-6971
46. Gurkan C., Symeonides S.N., and Ellar D.J. High-level production in Pichia pastoris of an anti-p185(HER-2) single-chain antibody fragment using an alternative secretion expression vector. Biotechnology and Applied Biochemistry 39 (2004) 115-122
47. Hackel B.J., Huang D., Bubolz J.C., Wang X.X., and Shusta E.V. Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae. Pharmaceutical Research 23 (2006) 790-797
48. Hagemeyer C.E., Tomic I., Weirich U., Graeber J., Nordt T., Runge M.S., Bode C., and Peter K. Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single chain antibody and low-molecular-weight urokinase. Journal of Thrombosis and Haemostasis 2 (2004) 797-803
49. Hagemeyer C.E., Schwartz M., and Karlheinz P. Single-chain antibodies as new antithrombotic drugs. Seminars in Thrombosis and Hemostasis 33 (2007) 185-195
50. Hayhurst A. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain. Protein Expression and Purification 18 (2000) 1-10
51. Heeboll-Nielsen A., Choe W.S., Middelberg A.P.J., and Thomas O.R.T. Efficient inclusion body processing using chemical extraction and high gradient magnetic fishing. Biotechnology Progress 19 (2003) 887-898
52. Ho M., Nagata S., and Pastan I. Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 9637-9642
53. Holliger P., and Hudson P.J. Engineered antibody fragments and the rise of single domains. Nature Biotechnology 23 (2005) 1126-1136
54. Hoogenboom H.R. Selecting and screening recombinant antibody libraries. Nature Biotechnology 23 (2005) 1105-1116
55. Huang D., and Shusta E.V. Secretion and surface display of green fluorescent protein using the yeast Saccharomyces cerevisiae. Biotechnology Progress 21 (2005) 349
56. Huang D., and Shusta E.V. A yeast platform for the production of single-chain antibody-green fluorescent protein fusions. Applied and Environmental Microbiology 72 (2006) 7748-7759
57. Hubbuch J.J., and Thomas O.R.T. High-gradient magnetic affinity separation of trypsin from porcine pancreatin. Biotechnology and Bioengineering 79 (2002) 301-313
58. Hudson P.J. Recombinant antibody constructs in cancer therapy. Current Opinion in Immunology 11 (1999) 548-557
59. Hust M., Jostock T., Menzel C., Voedisch B., Mohr A., Brenneis M., Kirsch M.I., Meier D., and Dubel S. Single chain Fab(scFab) fragment. BMC Biotechnology 7 (2007) 1-15
60. Huston J.S., McCartney J., Tai M.S., Mottola-Hartshorn C., Jin D., Warren F., Keck P., and Oppermann H. Medical applications of single-chain antibodies. International Reviews of Immunology 10 (1993) 195-217
61. Ideno A., Furutani M., Iwabuchi T., Iida T., Iba Y., Kurosawa Y., Sakuraba H., Ohshima T., Kawarabayashi Y., and Maruyama T. Expression of foreign proteins in Escherichia coli by fusing with an archaeal FK506 binding protein. Applied Microbiology and Biotechnology 64 (2004) 99-105
62. Khatri N.K., and Hoffmann F. Oxygen-limited control of methanol uptake for improved production of a single-chain antibody fragment with recombinant Pichia pastoris. Biotechnological Products and Process Engineering 72 (2006) 492-498
63. Kim D.M., and Swartz J.R. Efficient production of a bioactive, multiple disulphide-bonded protein. Biotechnology and Bioengineering 85 (2004) 122-129
64. King D.J., Byron O.D., Moutain A., Weir N., Harvey A., Lawson A.D.G., Proudfoot K.A., Baldock D., Harding S.E., Yarranton G.T., and Owens R.J. Expression, purification and characterization of B72.3 Fv fragments. Biochemical Journal 290 (1993) 723-729
65. Kipriyanov S.M., Moldenhauer G., Martin A.C., Kupriyanova O.A., and Little M. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity. Protein Engineering 10 (1997) 445-453
66. Kitchin K., Lin G.F., Shelver W.L., Murtaugh M.P., Pentel P.R., Pond S.M., Humphrey J.E., Smith J.M., and Flickinger M.C. Cloning, expression and purification of an anti-despiramine single chain antibody in NS/0 myeloma cells. Journal of Pharmaceutical Sciences 84 (1995) 1184-1189
67. Knappik A., and Pluckthun A. Engineered turns of a recombinant antibody improve its in vivo folding. Protein Engineering 8 (1995) 81-89
68. Kou G., Shi S., Wang H., Tan M., Xue J., Zhang D., Hou S., Qian W., Wang S., Dai J., Li B., and Guo Y. Preparation and characterization of recombinant protein ScFv(CD11c)-TRP2 for tumor therapy from inclusion bodies in Escherichia coli. Protein Expression and Purification 52 (2007) 131-138
69. Kretzschmar T., Aoustin L., Zingel O., Marangi M., Vonach B., Towbin H., and Geiser M. High-level expression in insect cells and purification of secreted monomeric single-chain Fv antibodies. Journal of Immunological Methods 195 (1996) 93-101
70. Kujau M.J., Hoischen C., Riesenberg D., and Gumpert J. Expression and secretion of functional miniantibodies McPC603scFvDhlx in cell-wall-less L-form strains of Proteus mirabilis and Escherichia coli: a comparison of the synthesis capacities of L-form strains with an E. coli producer strain. Applied Microbiology and Biotechnology 49 (1998) 51-58
71. Kumar P.K.R., Maschke H.E., Friehs K., and Schugert K. Strategies for improving plasmid stability in genetically modified bacteria in bioreactors. Trends in Biotechnology 9 (1991) 279-284
72. Leath C.A., Douglas J.T., Curiel D.T., and Alvarez R.D. Single-chain antibodies: a therapeutic modality for cancer gene therapy. International Journal of Oncology 24 (2004) 765-771
73. Lechat P., Mudgett-Hunter M., Margolies M.N., Haber E., and Smith T.W. Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments. Journal of Pharmacology and Experimental Therapeutics 229 (1984) 210-213
74. Lee M.H., Park T.I., Park Y.B., and Kwak J.W. Bacterial expression and in vitro refolding of a single-chain Fv antibody specific for human plasma apolipoprotein B-100. Protein Expression and Purification 25 (2002) 166-173
75. Lipovsek D., and Pluckthun A. In-vitro protein evolution by ribosome display and mRNA display. Journal of Immunological Methods 290 (2004) 51-67
76. Liu X.Y., Pop L.M., Roopenian D.C., Ghetie V., Vitetta E.S., and Smallshaw J.E. Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics. International Immunopharmacology 6 (2006) 791-799
77. Makvandi-Nejad S., McLean M.D., Hirama T., Almquist K.C., MacKenzie C.R., and Hall J.C. Transgenic tobacco plants expressing a dimeric single-chain variable fragment (scFv) antibody against Salmonella enterica serotype paratyphi B. Transgenic Research 14 (2005) 785-792
78. Malinowski D.P., Gourley M., Edelstein S., and Pearson R.E. Expression of a Chlamydia anticarbohydrate single-chain antibody as a maltose binding fusion protein. Cell Biophysics 21 (1992) 1-12
79. Martineau P., Jones P., and Winter G. Expression of an antibody fragment at high levels in the bacterial cytoplasm. Journal of Molecular Biology 280 (1998) 117-127
80. Milenic D.E., Yokota T., Filpula D.R., Finkelman M.A.J., Dodd S.W., Wood J.F., Whitlow M., Snoy P., and Schlom J. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Research 51 (1991) 6363-6371
81. Miller K.D., Weaver-Feldhaus J., Gray S.A., Siegel R.W., and Feldhaus M.J. Production, purification and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli. Protein Expression and Purification 42 (2005) 255-267
82. Nedelman M.A., Shealy D.J., Boutin R., Brunt E., Seasholtz J.I., Allen I.E., Weisman H.F., McCartney J.E., Warren F.D., Oppeimann H., Pang R.H.L., and Berger H.J. Rapid infarct imaging with a technetium-99m antimyosin recombinant single chain Fv: evaluation on a canine model of acute myocardial infarction. Journal of Nuclear Medicine 34 (1993) 234-241
83. Nieba L., Honegger A., Krebber C., and Pluckthun A. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Protein Engineering 10 (1997) 435-444
84. Novotny J., Bruccoleri R., Newell J., Murphy D., Haber E., and Karplus M. Molecular anatomy of the antibody binding site. Journal of Biological Chemistry 258 (1983) 4433-4437
85. Oelschlaeger P., Srikant-Iyer S., Lange S., Schmitt J., and Schmid R.D. Fluorophor-linked immunosorbent assay: a time- and cost-saving method for the characterization of antibody fragments using a fusion protein of a single-chain antibody fragment and enhanced green fluorescent protein. Analytical Biochemistry 309 (2002) 27-34
86. Owen M., Gandecha A., Cockburn B., and Whitelam G. Synthesis of a functional antiphytochrome single-chain-Fv protein in transgenic tobacco. Bio-technology 10 (1992) 790-794
87. Parekh R., Forrester K., and Wittrup D. Multicopy overexpression of bovine pancreatic trypsin inhibitor saturates the protein folding and secretory capacity of Saccharomyces cerevisiae. Protein Expression and Purification 6 (1995) 537-545
88. Pastan I., Hassan R., FitzGerald D.G., and Kreitman R.J. Immunotoxin therapy of cancer. Nature Reviews Cancer 6 (2006) 559-565
89. Pereboev A.V.A.C., Kawakami Y., Dong S.S., Blackwell J.L., Kashentseva E.A., Triozzi P.L., Aldrich W.A., Curiel D.T., Thomas J.M., and Dmitriev I.P. Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells. Gene Therapy 9 (2002) 1189-1193
90. Piervincenzi R.T., Reichert W.M., and Hellinga H.W. Genetic engineering of a single-chain antibody fragment for surface immobilization in an optical biosensor. Biosensors and Bioelectronics 13 (1998) 305-312
91. Proba K., Ge L., and Pluckthun A. Functional antibody single-chain fragments from the cytoplasm of Escherichia coli: influence of thioredoxin reductase (TrxB). Gene 159 (1995) 203-207
92. Proba K., Worn A., Honegger A., and Pluckthun A. Antibody scFv fragments without disulphide bonds made by molecular evolution. Journal of Molecular Biology 275 (1998) 245-253
93. Raag R., and Whitlow M. Single-chain Fvs. The Journal of the Federation of American Societies for Experimental Biology 9 (1995) 73-80
94. Reichert J.M., Rosensweig C.J., Faden L.B., and Dewitz M.C. Monoclonal antibody successes in the clinic. Nature Biotechnology 23 (2005) 1073-1078
95. Reiter Y., Brinkmann U., Webber K.O., Jung S.H., Lee B., and Pastan I. Stabilisation of the Fv fragments in recombinant immunotoxins by disulphide bonds engineered into conserved framework regions. Biochemistry 33 (1994) 5451-5459
96. Ridder R., Schmitx R., Legay F., and Gram H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. BioTechnology 13 (1995) 255-260
97. Riechmann L., Foote J., and Winter G. Expression of an antibody Fv fragment in myeloma cells. Journal of Molecular Biology 203 (1988) 825-828
98. Rippmann J.F., Klein M., Hoischen C., Brocks B., Rettig W.J., Gumpert J., Pfizenmaier K., Mattes R., and Moosmayer D. Procaryotic expression of single-chain variable-fragment (scFv) antibodies: secretion in L-form cells of Proteus mirabilis leads to active product and overcomes the limitations of periplasmic expression in Escherichia coli. Applied and Environmental Microbiology 64 (1998) 4862-4869
99. Robert R., Clofent-Sanchez G., Hocquellet A., Jacobin-Valat M.-J., Daret D., Noubhani A.M., and Santarelli X. Large-scale production, bacterial localization assessment and immobilized metal affinity chromatography purification of a human single-chain Fv antibody against alphaIIb-beta3 integrin. International Journal of Biological Macromolecules 39 (2006) 51-59
100. Robin S., Petrov K., Dintinger T., Kujumdzieva A., Tellier C., and Dion M. Comparison of three microbial hosts for the expression of an active catalytic scFv. Molecular Immunology 39 (2003) 729-738
101. Rosso M.N., Schouten A., Roosien J., Borst-Vressen T., Hussey R.S., Gommers F.J., Bakker J., Schots A., and Abad P. Expression and functional characterization of a single chain FV antibody directed against secretions involved in plant nematode infection process. Biochemical and Biophysical Research Communications 220 (1996) 255-263
102. Sanchez L., Ayala M., Freyre F., Pedroso I., Bell H., Falcon V., and Gavilondo J.V. High cytoplasmic expression in E-coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen. Journal of Biotechnology 72 (1999) 13-20
103. Schouten A., Roosien J., van Engelen F.A., de Jong G.A.M., Borst-Vrenssen A.W.M., Zilverentant J.F., Bosch D., Steikema W.J., Gommers F.J., Schots A., and Bakker J. The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Molecular Biology 30 (1996) 781-793
104. Schrama D., Reisfeld R.A., and Becker J.C. Antibody targeted drugs as cancer therapeutics. Nature Reviews Drug Discovery 5 (2006) 147-159
105. Sheets M.D., Amersdorfer P., Finnern R., Sargent P., Lindqvist E., Schier R., Hemingsen G., Wong C., Gerhart J.C., and Marks J.D. Efficient construction of a large non-immune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 6157-6162
106. Shimada N., Suzuki Y., Nakajima M., Conrad U., Murofushi N., and Yamaguchi I. Expression of functional single-chain antibody against GA(24/19) in transgenic tobacco. Bioscience Biotechnology and Biochemistry 63 (1999) 779-783
107. Shusta E.V., Raines R.T., Pluckthun A., and Wittrup K.D. Increasing the secretory capacity of Saccharomyces cerevisiae for production of single-chain antibody fragments. Nature Biotechnology 16 (1998) 773-777
108. Shusta E.V., Holler P.D., Kieke M.C., Kranz D.M., and Wittrup K.D. Directed evolution of a stable scaffold for T-cell receptor engineering. Nature Biotechnology 18 (2000) 754-759
109. Sinacola J.R., and Robinson A.S. Rapid refolding and polishing of single chain antibodies from Escherichia coli inclusion bodies. Protein Expression and Purification 26 (2002) 301-308
110. Skerra A. Bacteria expression of immunoglobulin fractions. Current Opinion in Immunology 5 (1993) 256-262
111. Skerra A., and Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240 (1988) 1038-1041
112. Sletta H., Nedal A., Aune T.E.V., Hakvag S., Aune R., Ellingsen T.E., Valla S., and Brautaset T. Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli. Applied and Environmental Microbiology 70 (2004) 7033-7039
113. Smith J.D., and Robinson A.S. Overexpression of an archaeal protein in yeast: secretion bottleneck at the ER. Biotechnology and Bioengineering 79 (2002) 713-723
114. Smith M.D. Antibody production in plants. Biotechnology Advances 14 (1996) 267-281
115. Sotiriadis A., and Keshavarz-Moore E. Factors affecting the production of a single-chain antibody fragment by Aspergillus awamori in a stirred tank reactor. Biotechnology Progress 17 (2001) 618-623
116. Stancovski I., Schindler D.G., Waks T., Yarden Y., Sela M., and Eshhar Z. Targeting of T lymphocytes to Nue HER2-expressing cells using chimeric single chain Fv receptors. Journal of Immunology 151 (1993) 6577-6582
117. Tai M.S., Mudgett-Hunter M., Levinson D., Wu G.M., Haber E., Oppermann H., and Hustaon J.S. A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry 29 (1990) 8024-8030
118. Takkinen K., Laukkanen M.L., Sizmann D., Alfthan K., Immonen T., Vanne L., Kaartinen M., Knowles J.K.C., and Teeri T.T. An active single-chain antibody containing a cellulose linker domain is secreted by Escherichia coli. Protein Engineering 4 (1991) 837-841
119. Tavladoraki P., Benvenuto E., Trinca S., De Martinis D., Cattaneo A., and Galeffi P. Nature 366 (1993) 469-472
120. Theisen D.M., Pongratz C., Wiegmann K., Rivero F., Krut O., and Kronke M. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies. Vaccine 24 (2006) 3127-3136
121. Trentmann O., Khatri N.K., and Hoffmann F. Reduced oxygen supply increases process stability and product yield with recombinant Pichia pastoris. Biotechnology Progress 20 (2004) 1766-1775
122. Trinh R., Gurbaxani B., Morrison S.L., and Seyfzadeh M. Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression. Molecular Immunology 40 (2004) 717-722
123. Urban J.H., Schneider R.M., Compte M., Finger C., Cichutek K., Alvarez-Vallina L., and Buchholz C.J. Selection of functional human antibodies from retroviral display libraries. Nucleic Acids Research 33:e35 (2005) 1-8
124. Verma R., Boleti E., and George A.J.T. Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. Journal of Immunological Methods 216 (1998) 165-181
125. von Minckwitz G., Harder S., Hövelmann S., Jäger E., Al-Batran S.E., Loibl S., Atmaca A., Cimpoiasu C., Neumann A., Abera A., Knuth A., Kaufmann M., Jäger D., Maurer A.B., and Wels W.S. Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas. Breast Cancer Research 7 (2005) R617-R626
126. Ward E.S., Gussow D., Griffiths A.D., Jones P.T., and Winter G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 341 (1989) 544-546
127. Whitelam G.C., Cockburn B., and Owen M.R.L. Antibody-production in transgenic plants. Biochemical Society Transactions 22 (1994) 940-944
128. Williams A.F., and Barclay A.N. The immunoglobulin superfamily, domains for cell surface recognition. Annual Review of Immunology 6 (1988) 381-405
129. Wolkowicz R., Jager G.C., and Nolan G.P. A random peptide library fused to CCR5 for selection of mimetopes expressed on the mammalian cell surface via retroviral vectors. Journal of Biological Chemistry 280 (2005) 15195-15201
130. Worn A., and Pluckthun A. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulphide bonds and fold correctly. FEBS Letters 237 (1998) 357-361
131. Worn A., and Pluckthun A. Stability engineering of antibody single-chain Fv fragments. Journal of Molecular Biology 305 (2001) 989-1010
132. Worn A., Auf der Maur A., Escher D., Honegger A., Barberis A., and Pluckthun A. Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors. Journal of Biological Chemistry 275 (2000) 2795-2803
133. Wu C.H., Balasubramanian W.R., Ko Y.P., Hsu G., Chang S.E., Prijovich Z.M., Chen K.C., and Roffler S.R. A simple method for the production of recombinant proteins from mammalian cells. Biotechnology and Applied Biochemistry 40 (2004) 167-172
134. Wu S.C., Yeung J.C., Duan Y., Ye R., Szarka S.J., Habibi H.R., and Wong S.L. Functional production and characterization of a fibrin-specific single-chain antibody-fragment from Bacillus subtilitis: effects of molecular chaperones and a wall-bound protease on antibody fragment production. Applied and Environmental Microbiology 68 (2002) 3261-3269
135. Wulfing C., and Pluckthun A. Protein folding in the periplasm of Escherichia coli. Molecular Microbiology 12 (1994) 685-692
136. Xu P., Doyle III F.J., and Robinson A.S. Analysis of unfolded protein response during single-chain antibody expression in Saccharomyces cerevisiae reveals different roles for BiP and PDI in folding. Metabolic Engineering 7 (2005) 269-279
137. Yokota T., Milenic D.E., Whitlow M., and Schlom J. Rapid tumour penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Research 52 (1992) 3402-3408
138. Young N.M., MacKenzie C.R., Narang S.A., Oomen R.P., and Baenziger J.E. Thermal stabilization of a single-chain Fv antibody fragment by introduction of a disulphide bond. FEBS Letters 377 (1995) 135-139
139. Zheng L., Baumann U., and Reymond J.L. Production of a functional catalytic antibody ScFv-NusA fusion protein in bacterial cytoplasm. Journal of Biochemistry (Tokyo) 133 (2003) 577-581